Gabapentin Tablet, Film Coated
Product Images NDC 68382-204

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68382-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 01

This text contains information related to the calculation of creatinine clearance (CLCr) using the equation which involves the patient's weight in grams and serum creatinine in mg/dL. There is a factor of 0.35 for female patients. However, without additional context, it is not possible to determine the purpose or application of this calculation.*

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 02

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 03

This document appears to be a chart or graph showing pain scores during a clinical trial for a pain medication. The chart shows a 4-week dose titration period followed by a 4-week fixed dose period with either a placebo or gabapentin at 3600 mg/day. There is also a baseline measurement. The only data shown in the document is a mean pain score of 10, with no indication of what scale was used.*

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 04

This is a chart showing the results of a study with a 3-week dose titration period followed by a 4-week fixed dose period. The study compares the effects of a placebo with two different doses of gabapentin (1800 mg/day and 2400 mg/day) on mean pain score. There are six time points measured in weeks. No other information is available.*

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 05

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 06

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 07

This is a description of Gabapentin tablets, a medication with the National Drug Code 68382-204-01. The tablets come in 100 count bottles and are distributed by Synergy Pharmaceuticals, a division of Zydus Pharmaceuticals. The tablets contain 600mg of Gabapentin and should be stored at room temperature. The dosage and administration instructions are not clear from the output. Contraindications and side effects are not provided.*

FDA Label Image

49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 08

This is the packaging label of a drug called Gabapentin, with the NDC code 68382-205-01. It contains 100 tablets of 800 mg. The manufacturer is Cadis Featherheart L and it is distributed by Zydus Pharmaceuticals in the USA. The label includes information about the usual dosage, prescription details, storage, and precautions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.